References
Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139
Joannidis M, Druml W, Forni LG, Groeneveld AB, Honore P, Oudemans-van Straaten HM, Ronco C, Schetz MR, Woittiez AJ (2010) Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM. Intensive Care Med 36:392–411
Jones D, McEvoy S, Merz TM, Higgins A, Bellomo R, Cooper JD, Hollis S, McArthur C, Myburgh JA, Taylor C, Liu B, Norton R, Finfer S (2010) International albumin use: 1995 to 2006. Anaesth Intensive Care 38:266–273
Briegel I, Dolch M, Rehm M, Thiel M, Schelling G (2007) Hydroxyethylstarch increases the risk for acute renal failure in patients with severe ARDS. Anesthesiology 107:A1514
Wiedermann CJ, Wiedermann W, Joannidis M (2010) Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensive Care Med 36:1657–1665
Wiedermann CJ, Dunzendorfer S, Gaioni LU, Zaraca F, Joannidis M (2010) Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care 14:R191
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Briegel, I., Rehm, M., Briegel, J. et al. Replacement of albumin by hydroxyethylstarch could increase the risk for acute kidney injury in patients with severe ARDS. Intensive Care Med 37, 719–720 (2011). https://doi.org/10.1007/s00134-010-2115-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-010-2115-y